Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease-Reference-Cited by-同舟云学术

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

Published:2005 Issue:6 Volume:20 Page:674-679
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Saft Carsten,Zange Jochen,Andrich Jürgen,Müller Klaus,Lindenberg Katrin,Landwehrmeyer Bernhard,Vorgerd Matthias,Kraus Peter H.,Przuntek Horst,Schöls Ludger

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference25 articles.

1. Formation of Polyglutamine Inclusions in Non-CNS Tissue

2. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation

3. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

4. Mitochondria and degenerative disorders

5. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurodegenerative disorders, metabolic icebergs, and mitohormesis;Translational Neurodegeneration;2024-09-06

2. Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model;CNS Neuroscience & Therapeutics;2024-09

3. Dysregulation of choline metabolism and therapeutic potential of citicoline in Huntington's disease;Aging Cell;2024-08-14

4. Platelet Bioenergetics and Associations With Delirium and Coma in Patients With Sepsis;CHEST Critical Care;2024-06

5. Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions;International Journal of Molecular Sciences;2024-04-25